d gaser
08 Jan 2018
Re: We are going backward I fear . Raptor sorry but have you read the notice you posted ? its talking about Sept 2017 , the Barclays notice I posted ,was dated Jan 2018. Happy new year every body BE HAPPYDav
dave297
06 Jan 2018
Re: We are going backward I fear . I would be delirious with 178.89 !
raptor66
05 Jan 2018
Re: We are going backward I fear . Vectura Group (VEC) Rating Reiterated by Shore CapitalPosted by Erica Schwartz on Jan 4th, 2018 Vectura Group (LON:VEC)‘s stock had its “buy” rating reaffirmed by analysts at Shore Capital in a report issued on Thursday.Several other equities analysts have also issued reports on VEC. Peel Hunt reiterated a “hold” rating and issued a GBX 160 ($2.14) target price on shares of Vectura Group in a research note on Wednesday, September 6th. Numis Securities reiterated a “buy” rating and issued a GBX 205 ($2.74) target price on shares of Vectura Group in a research note on Thursday, September 7th. Citigroup cut their target price on Vectura Group from GBX 200 ($2.67) to GBX 180 ($2.41) and set a “buy” rating on the stock in a research note on Monday, September 18th. JPMorgan Chase & Co. cut their target price on Vectura Group from GBX 210 ($2.81) to GBX 180 ($2.41) and set an “overweight” rating on the stock in a research note on Thursday, September 21st. Finally, Panmure Gordon reiterated a “buy” rating and issued a GBX 150 ($2.01) target price on shares of Vectura Group in a research note on Thursday, November 9th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Vectura Group has a consensus rating of “Buy” and an average target price of GBX 177.89 ($2.38).
d gaser
05 Jan 2018
Re: We are going backward I fear . I have Just received my Barclays mid day up date, and it appears shore capital have down graded VEC ,That's not a good end to the week, nor a good start to a new year. .Quote Insurer Admiral was hit by a downgrade to 'underweight' at JPMorgan, while recruiter Pagegroup retreated following a downgrade by Morgan Stanley, and Vectura was knocked by a downgrade from Shore Capital. Admiral was also likely to be taking a hit from news that UK car sales fell for the first time in six years last year.Happy New Year every one BE HAPPYDAVE
Ambiorix1
05 Jan 2018
Re: Going backward I fear . I wonder if you noticed only 10% of the share buyback has been executed so far. IMO the SP will still be supported for some time to come….Ambiorix.
Simbrad
21 Jun 2016
N1Singer put out a note this morning on it... "The merger between Skyepharma and Vectura has created a global leader in the development of therapeutic respiratory products, with strong global partners and broad development capability across multiple formulation platforms, drug classes and delivery forms. In this report we outline the company’s three strongest valuation drivers, a selection of high-potential development programmes and the financial outlook for the enlarged group." taken from Research Tree
Daiyama
12 Jan 2016
200.10 a short glimpse of the bright future which is ahead of us!
Daiyama
11 Dec 2014
Translated into plain english: severe asthma patient use besides inhaled cortico steroids (ics) also orally cortico steroids (ocs). ocs usually have quite severe side effects (whereas ics have much lower side effects. there it is always good for asthma patients who require ocs to reduce the ocs dose while maintaining there asthma status. at least to my knowledge there is no medication available today which can reduce ocs dose.
